Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: Prognostic Indicators as Provided by the EPIC ClearView
A completed clinical trial update from EPIC ClearView describing prognostic indicators across several conditions.
-
FDA label_change · 2011-11-17FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for HYZAAR, a fixed-dose combination of losartan potassium and hydrochlorothiazide, submitted by…
-
CLINICAL_TRIALS research · 2011-11-16Clinical Trial Update: Vitamin D Augmentation of Tekturna (Aliskiren) in Hypertension [Phase 4]
Phase 4 clinical trial update on vitamin D augmentation of aliskiren (Tekturna) for hypertension; current status is unknown.
-
FDA approval · 2011-11-15FDA Approved: MOEXIPRIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Moexipril Hydrochloride by Teva Pharmaceuticals USA, Inc. Moexipril Hydrochloride is an ACE inhi…
-
CLINICAL_TRIALS trial_result · 2011-11-15Clinical Trial Update: Study to Improve Quality of Care and Patient Health in the Field of Cardiovascular Risk Factors in General Practice [Phase 4]
Clinical trial update noting completion of a Phase 4 study aimed at improving quality of care and patient health in high-risk hypertensive p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-11-15Clinical Trial Update: Laparoscopic Adjustable Gastric Banding With Truncal Vagotomy [NA]
The clinical trial of laparoscopic adjustable gastric banding with truncal vagotomy was terminated, and the update notes the status without …
-
FDA approval · 2011-11-14FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for AZOR, a fixed-dose combination of amlodipine besylate and olmesartan medoxomil, submitted by Cos…
-
FDA approval · 2011-11-14FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)
FDA approved a supplemental application for Verapamil hydrochloride submitted by Teva Pharmaceuticals Inc. This action finalizes changes to …
-
FDA approval · 2011-11-14FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Exelan Pharmaceuticals Inc.)
FDA approved a supplemental application for hydrochlorothiazide submitted by Exelan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2011-11-11Clinical Trial Update: Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors [Phase 4]
Phase 4 trial comparing Caduet to usual care in subjects with hypertension and additional risk factors; completed with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients [Phase 3]
Phase 3 trial evaluating the safety and efficacy of valsartan used alone and in combination with amlodipine for hypertension has completed, …
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension [Phase 3]
Phase 3 trial assessing the valsartan/amlodipine combination in patients with severe hypertension demonstrated efficacy in lowering blood pr…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension [Phase 3]
Phase 3 trial assessing the safety of the valsartan and amlodipine combination in hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: SPP100 Dose Finding Study in Japan [Phase 2]
A Phase 2 dose-finding trial of SPP100 in Japan for hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine [Phase 3]
Phase 3 clinical trial comparing the long-term efficacy and safety of an aliskiren-based regimen against a hydrochlorothiazide-based regimen…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure. [Phase 3]
A Phase 3 dose-ranging trial evaluated the safety and efficacy of aliskiren at 150 mg, 300 mg, and 600 mg versus placebo in patients with hy…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood Pressure [Phase 3]
A Phase 3 dose-ranging trial evaluating the safety and efficacy of aliskiren for hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine [Phase 3]
A Phase 3 trial comparing long-term efficacy and safety of an aliskiren-based regimen with a hydrochlorothiazide-based regimen, with optiona…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: An Enhanced Medication Monitoring Program [Phase 1]
Phase 1 clinical trial update on an enhanced medication monitoring program addressing hypertension and medication adherence.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension [Phase 4]
Phase 4 trial evaluating whether combining amlodipine besylate with benazepril is more effective than amlodipine alone for severe hypertensi…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure. [Phase 4]
A Phase 4 trial by Novartis evaluated whether valsartan, with or without other blood pressure medications, improves the heart's filling, pum…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 clinical trial update evaluating the efficacy of the amlodipine/benazepril combination in hypertensive African-American patients wit…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension [Phase 3]
Phase 3 trial evaluating a valsartan/Hydrochlorothiazide combination for severe hypertension has completed. The update notes completion but …
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome [Phase 4]
Phase 4 trial update evaluating the effects of 12 weeks of high-dose valsartan (320 mg) added to amlodipine on endothelial function in hyper…
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension [Phase 3]
A long-term safety study of aliskiren, alone or with hydrochlorothiazide, in essential hypertension has completed Phase 3 testing.